about
Vaccinology in the third millennium: scientific and social challengesGenome-wide association study of antibody response to smallpox vaccineTrends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomicsCytokine production associated with smallpox vaccine responsesA systems biology approach to the effect of aging, immunosenescence and vaccine responseThe weight of obesity on the human immune response to vaccinationImmunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responsesExtended LTA, TNF, LST1 and HLA gene haplotypes and their association with rubella vaccine-induced immunityGenome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipientsAssociations between measles antibody levels and the protein structure of class II human leukocyte antigens.Turkey versus guinea pig red blood cells: hemagglutination differences alter hemagglutination inhibition responses against influenza A/H1N1.Accurate mass precursor ion data and tandem mass spectrometry identify a class I human leukocyte antigen A*0201-presented peptide originating from vaccinia virus.Polymorphisms in the vitamin A receptor and innate immunity genes influence the antibody response to rubella vaccination.Integration of Immune Cell Populations, mRNA-Seq, and CpG Methylation to Better Predict Humoral Immunity to Influenza Vaccination: Dependence of mRNA-Seq/CpG Methylation on Immune Cell PopulationsRubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genesEffect of human leukocyte antigen homozygosity on rubella vaccine-induced humoral and cell-mediated immune responsesThe immunology of smallpox vaccines.Gender effects on humoral immune responses to smallpox vaccine.Influenza virus resistance to antiviral agents: a plea for rational use.Testing vaccines in pediatric research subjects.Predominant inflammatory cytokine secretion pattern in response to two doses of live rubella vaccine in healthy vaccineesAssociations between SNPs in candidate immune-relevant genes and rubella antibody levels: a multigenic assessmentResponse surface methodology to determine optimal cytokine responses in human peripheral blood mononuclear cells after smallpox vaccination.2'-5'-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine.Adversomics: the emerging field of vaccine adverse event immunogeneticsAssociations between single nucleotide polymorphisms in cellular viral receptors and attachment factor-related genes and humoral immunity to rubella vaccination.The personal touch: strategies toward personalized vaccines and predicting immune responses to them.SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccineGenome-wide SNP associations with rubella-specific cytokine responses in measles-mumps-rubella vaccine recipientsTranscriptional signatures of influenza A/H1N1-specific IgG memory-like B cell response in older individualsHLA genotypes and rubella vaccine immune response: additional evidence.HLA alleles associated with the adaptive immune response to smallpox vaccine: a replication studyVaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery?Genetic basis for variation of vaccine response: our studies with rubella vaccineRace and sex-based differences in cytokine immune responses to smallpox vaccine in healthy individualsGenome-wide genetic associations with IFNγ response to smallpox vaccineSingle-nucleotide polymorphism associations in common with immune responses to measles and rubella vaccines.Identification of HLA-DRB1-bound self-peptides following measles virus infection.Characterization of humoral and cellular immunity to rubella vaccine in four distinct cohorts.Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides.
P50
Q24261399-BFC09E2D-9C32-4C30-972C-469CB5DD01AEQ24612100-FA5B2C0C-55F0-46CD-BF5E-A659DA0F730AQ24648874-F4715862-0820-41E0-9128-27018907D3C3Q26823501-6DEA246C-AAA8-44EF-B39E-EC4B41DA874EQ26994749-C61C8169-74BE-4EEA-876E-4543FC35C5A1Q28088540-9B009252-FD49-4B6A-98B3-5056358E8771Q28285300-67C5833E-2B82-4B75-8BF2-1DC60B5A4029Q28750199-E65A6B5E-87B6-4831-9063-5C66AB418EEDQ28943252-89481EDC-D50D-4028-ACB2-219C58841C02Q30333088-CD5F9024-6C5C-49EC-88BF-25A5356E9C6EQ30362094-91F9FD78-A8C1-49D6-BF85-370D899EC096Q31007306-E892618D-E2BA-42C2-ACCD-9DC56284FB6BQ33556985-591923F5-8533-4270-9F07-22F6A2ED0F86Q33586172-A4E8145A-0C09-45AE-8AF0-48F111538470Q33604187-BAC835B6-7479-4A01-A33B-DB86D09C9A97Q33625437-04217CB8-5207-49C3-8009-A9BA78C69290Q33679943-D938CB95-1815-483A-84E7-CA18CC2D9158Q33701473-016C9D58-FBD8-496F-88BF-C5B745CC0EC4Q33701528-35857091-0175-43E9-B3F7-675FDBB17FF2Q33701535-E937419A-9435-49E2-8E78-058C7A08EE7CQ33706043-CA01B5D5-E09A-436D-B372-9F7D405EB5ABQ33711018-DB2BC908-86EB-4C25-89FF-284F513FF98DQ33714136-70F09404-71C7-4334-9BD9-B7A968E75B31Q33742272-9D7DE12A-1626-4850-B782-7EE7358133DAQ33744268-20231BEA-DA13-4A64-B70F-ACE71115DBCCQ33778981-1EB376D5-D1C7-429D-B3F2-4B30879E0005Q33813977-220916FA-73D8-4743-BCA5-36383CB894F4Q33824586-41835EC7-A9B0-4864-8A89-5D8EFB65E04AQ33894025-037EA072-3107-444A-8FFD-287EE9B0A7ECQ33922317-1932BF38-D436-4DD8-BD9D-40AB28EAA086Q34014935-09AC5719-6E89-4D9D-8A6D-9A16D900BBF9Q34024252-8543F376-AC67-4721-A701-5446C882F544Q34126261-BE4CB49D-A225-461A-B2CD-1571149423F3Q34215023-F71EE9A7-8E3C-435C-AA90-4F7C944FB2A4Q34221463-7C663991-0F4F-4A99-A7B9-6BEA8A8FE1ACQ34221936-336FABF5-FA54-4290-9E39-F207359A4F42Q34345266-23282777-FC3B-412E-9FC0-D5E502E10152Q34404576-0F35E57B-8421-44FE-B4DC-4104A0A1F738Q34419456-3903C203-1106-4400-B1FB-3C4445EE056AQ34554618-DC0F355C-A2D9-4558-A64E-D0CBDA18ABA4
P50
name
Inna G Ovsyannikova
@en
type
label
Inna G Ovsyannikova
@en
prefLabel
Inna G Ovsyannikova
@en